How changes in healthcare delivery affect cancer care quality
The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care
This study looks at how changes in healthcare delivery affect the quality of cancer care for patients, especially those who rely on Medicare and Medicaid, to see how these changes impact their treatment and overall health over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11044385 on NIH RePORTER |
What this research studies
This research investigates how the evolving healthcare delivery system impacts the quality of oncology care, particularly for vulnerable populations. It utilizes a novel national database that combines various data sources to analyze the integration of cancer care over time. By examining longitudinal data, the research aims to understand how changes in care delivery affect patient outcomes, including the adoption of new therapies and overall care quality. The focus is on patients enrolled in Medicare and Medicaid, ensuring a comprehensive view of care across different healthcare settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients, particularly those from rural areas, low-income backgrounds, or racial/ethnic minorities.
Not a fit: Patients who are not receiving cancer treatment or those who do not fall into the vulnerable categories may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer care quality and accessibility for underserved populations.
How similar studies have performed: Previous research has shown that analyzing healthcare delivery systems can lead to significant improvements in patient outcomes, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Keating, Nancy L — Harvard Medical School
- Study coordinator: Keating, Nancy L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.